Iodine-131 radioembolization boosts the immune activation enhanced by icaritin/resiquimod in hepatocellular carcinoma DOI Creative Commons

Xinyi Li,

Yuyi Qian,

Xin Lu

et al.

Journal of Controlled Release, Journal Year: 2024, Volume and Issue: 378, P. 849 - 863

Published: Dec. 31, 2024

Transarterial radioembolization (TARE) is a recommended locoregional strategy for intermediate hepatocellular carcinoma (HCC), whereas, the effect insufficient to reverse immunosuppression tumor microenvironment, and overall benefits patients remain be improved. In this study, multifunctional microsphere (MS)

Language: Английский

Research progress and prospect of tumor nanovaccine combination therapy strategy DOI
Yanyan Yin, Jun Guo, Shuo Zhang

et al.

Chinese Chemical Letters, Journal Year: 2024, Volume and Issue: unknown, P. 110771 - 110771

Published: Dec. 1, 2024

Language: Английский

Citations

0
Iodine-131 radioembolization boosts the immune activation enhanced by icaritin/resiquimod in hepatocellular carcinoma DOI Creative Commons

Xinyi Li,

Yuyi Qian,

Xin Lu

et al.

Journal of Controlled Release, Journal Year: 2024, Volume and Issue: 378, P. 849 - 863

Published: Dec. 31, 2024

Transarterial radioembolization (TARE) is a recommended locoregional strategy for intermediate hepatocellular carcinoma (HCC), whereas, the effect insufficient to reverse immunosuppression tumor microenvironment, and overall benefits patients remain be improved. In this study, multifunctional microsphere (MS)

Language: Английский

Citations

0